Processing your payment...
Please do not close your browser.

Facial Injectable Market - Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions and By Key Players: Bloomega BioTechnology, Allergan, Merz Pharma, Bausch Health (NYSE: BHC), Galderma, Integra Lifesciences (NasdaqGS: IART)

24 May, 2022 | 96 Pages
Shares
facebook sharing button
linkedin sharing button
twitter sharing button
sharethis sharing button

Over the next five years the Facial Injectable market will register a 26% CAGR in terms of revenue, the global market size will reach USD 86084.95 million by 2027.



Facial Injectable Market Overview



By 2027, the Facial Injectable Market will be worth USD 86084.95 million, with a CAGR of 26%. Traditional syringes, needle-free injectors, auto, and pen injectors have all been employed for medication administration in the treatment of medical illnesses, particularly cancer and autoimmune disorders. High-end and advanced technology-based items make up the facial injectable industry. The market is driven by the rising prevalence of chronic diseases, the expanding usage of self-injectable devices, and the expansion of FDA approvals. Furthermore, there is a steady increase in the geriatric population. Along with the elderly, the younger generation is increasingly drawn to the cosmetic sector in order to appear youthful.



The report aspects discussed the profile of the top manufacturers of the global Facial Injectable market. These aspects include financial status of major companies, trending advancements and entire market scenario. Growth of the report have examined Facial Injectable Market production, demand and growth potential, geographic analysis, as well as current market developments in various regions and countries.



Who are the Major Players in Facial Injectable Market?



The Facial Injectable Market is growing at a very fast pace and has seen the focus of many local and regional vendors offering precise application products for multiple end users. The three dependencies for the status of major companies in the market are: company profile, profitable gross margin, the prices they charge. These are the main players in this market Bloomega BioTechnology, Allergan, Merz Pharma, Bausch Health, Galderma, Integra Lifesciences, Tei Biosciences, Fibrogen and others.






Industry News:



Bausch + Lomb and Clearside Biomedical Announce FDA Approval of XIPERE™ (triamcinolone acetonide injectable suspension) for Suprachoroidal Use for the Treatment of Macular Edema Associated with Uveitis



Oct. 25, 2021 -- Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), and Clearside Biomedical, Inc. (Nasdaq: CLSD) ("Clearside"), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), today announced that the U.S. Food and Drug Administration (FDA) has approved XIPERE™ (triamcinolone acetonide injectable suspension) for suprachoroidal use for the treatment of macular edema associated with uveitis, a form of eye inflammation.



What are the major Applications, Types and Regions for Facial Injectable Market?



By Type, it is segmented into




  • Hyaluronic Acid

  • Collagen

  • Botulinum Toxin

  • Polymers

  • Particles



By Applications it is segmented into




  • Hospitals

  • Clinics

  • Research

  • Others



Facial Injectable Market Regional Analysis



In 2020, North America will account for 41% of global sales. Over the forecast period, the large senior population in the United States and Canada is predicted to increase demand for face injectables. During the projection period, new product releases by prominent industry players in North America will also fuel market growth.




  • North America

    • US

    • Canada



  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe



  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • Rest of the World

    • Middle East & Africa

    • Latin America





The Facial Injectable Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Facial Injectable Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.



What is our Facial Injectable Market report scope?























































 



Report Attributes



 



 



Report Details



 



Forecast Period 2022 to 2027 CAGR



 



CAGR of 26% during the review period (2022 to 2027).



 



By Type




  • Hyaluronic Acid

  • Collagen

  • Botulinum Toxin

  • Polymers

  • Particles



 



By Application




  • Hospitals

  • Clinics

  • Research

  • Others



 



 



 



By Companies



 



 



Bloomega BioTechnology, Allergan, Merz Pharma, Bausch Health, Galderma, Integra Lifesciences, Tei Biosciences, Fibrogen



 



 



 



Regions Covered



 




  • North America

  • Europe

  • Asia-Pacific

  • Rest of the World



 



 



 



 



 



 



 



 



Countries Covered




  • US

  • Canada

  • Germany

  • France

  • UK

  • Italy

  • Spain

  • Rest of Europe

  • China

  • Japan

  • India

  • Australia

  • South Korea

  • Rest of Asia-Pacific

  • Middle East & Africa

  • Latin America



 



Base Year



 



 



2022



 



Historical Year



 



 



2017 to 2021



Forecast Year



 



2022 to 2027



Number of Pages



98



 



Customization Available



 



 



Yes, the report can be customized as per your needs




 Key Takeaways from this Facial Injectable Report




  • Evaluate Facial Injectable market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, end use applications and by different industry verticals.

  • Understand the different dynamics influencing the market - growth driving factors, specific challenges and hidden opportunities.

  • Get in-depth insights on your competitor performance – revenue, shares, business strategies, financial benchmarking, product benchmarking, SWOT analysis and more.

  • Analyze the sales and distribution channels across geographies to enhance top-line revenues.

  • Understand the demanding supply chain with a deep dive on the value augmentation at each, in order to optimize value and bring efficiencies in your processes.

  • Get a quick outlook on the Facial Injectable market entropy - M&A's, deals, partnerships, product launches of all key players for the past 4 years.

  • Evaluate the import-export statistics, supply-demand and competitive landscape for more than top 20 countries globally for the market.



All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.



Frequently Asked Questions



What is the study period of this market?



The Facial Injectable Market is studied from 2017 - 2027.



What is the growth rate of Facial Injectable Market?



The Facial Injectable Market is growing at a CAGR of 26% over the next 5 years.



Who are the key players in Facial Injectable Market?



Bloomega BioTechnology, Allergan, Merz Pharma, Bausch Health, Galderma, Integra Lifesciences, Tei Biosciences, Fibrogen



What region does this Facial Injectable Market report covers?



North America (the United States, Canada, and Mexico)



Europe (Germany, France, UK, Russia, and Italy)



Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)



South America (Brazil, Argentina, Colombia, etc.)



The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)



What are the significant types of Facial Injectable Market?



Hyaluronic Acid, Collagen, Botulinum Toxin, Polymers, Particles



What are the major end-use applications of Facial Injectable Market?



Hospitals, Clinics, Research, Others


  1. INTRODUCTION

    1. MARKET DEFINATION

    2. MARKET DYNAMICS

    3. MARKET SEGMENTATION

    4. REPORT TIMLINES

    5. KEY STAKEHOLDERS



  2. RESEARCH METHODOLOGY

    1. DATA MINING

      1. SECONDARY RESEARCH

      2. PRIMARY RESEARCH

      3. SUBJECT MATTER EXPERT ADVICE



    2. QUALITY CHECK

    3. FINAL REVIEW

      1. DATA TRIANGULATION

      2. BOTTOM-UP APPROACH

      3. TOP-DOWN APPROACH



    4. RESEARCH FLOW



  3. EXECUTIVE SUMMARY

    1. INTRODUCTION

    2. GLOBAL FACIAL INJECTABLE MARKET BY TYPES

    3. GLOBAL FACIAL INJECTABLE MARKET BY APPLICATION



  4. MARKET DYNAMICS

    1. DRIVERS

      1. INCREASING DEMAND OF FACIAL INJECTABLE



    2. RESTRAINTS

      1. STRINGENT ENVIRONMENTAL REGUALTIONS

      2. HIGH COST OF RAW MATERIAL



    3. OPPORTUNITIES

      1. FACIAL INJECTABLE GROWTH

      2. APPLICATION OF FACIAL INJECTABLE



    4. IMPACT OF COVID 19



  5. GLOBAL FACIAL INJECTABLE MARKET, BY TYPES

    1. INTRODUCTION

    2. HYALURONIC ACID

    3. COLLAGEN

    4. BOTULINUM TOXIN

    5. POLYMERS

    6. PARTICLES

    7. OTHERS



  6. GLOBAL FACIAL INJECTABLE MARKET, BY APPLICATIONS

    1. INTRODUCTION

    2. HOSPITALS

    3. CLINICS

    4. RESEARCH

    5. OTHERS



  7. GLOBAL FACIAL INJECTABLE MARKET, BY REGION

    1. NORTH AMERICA

      1. US

      2. CANADA

      3. MEXICO



    2. EUROPE

      1. GERMANY

      2. FRANCE

      3. UK

      4. ITALY

      5. RUSSIA

      6. REST OF EUROPE



    3. APAC

      1. CHINA

      2. SOUTH KOREA

      3. JAPAN

      4. INDIA

      5. AUSTRALIA

      6. ASEAN

      7. REST OF APAC



    4. MIDDLE EAST & AFRICA

      1. SAUDI ARABIA

      2. UAE

      3. SOUTH AFRICA

      4. TURKEY

      5. REST OF MEA



    5. SOUTH AMERICA

      1. BRAZIL

      2. REST OF MEA

      3. ARGENTINA

      4. REST OF SOUTH AMERICA





  8. COMPETITIVE LANDSCAPE

    1. MERGERS, ACQUISITIONS, JOINT VENTURES, COLLABORATIONS,

    2. AND AGREEMENTS

      1. KEY DEVELOPMENT



    3. MARKET SHARE (%) **/RANKING ANALYSIS

    4. STRATEGIES ADOPTED BY LEADING PLAYERS



  9. COMPANY PROFILES

    1. BUSINESS OVERVIEW

    2. COMPANY SNAPSHOT

    3. PRODUCT BENCHMARKING

    4. STRATEGIC INITIATIVES

      1. Bloomega BioTechnology

      2.  Allergan

      3.  Merz Pharma

      4.  Bausch Health

      5.  Galderma

      6.  Integra Lifesciences

      7.  Tei Biosciences

      8.  Fibrogen





SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

  • Single User License
    $2500
  • Site License
    $3000
  • Global License
    $5000

How can we help you?

Reach us with your research requirements and we shall provide the optimum solution to suit your needs.

Curioust about Multiple Reports?

Discounts available for multiple report purchases.

Contact Us

Our Clients

  • 3M
  • Merck
  • IBM
  • Dow
  • Henkel
  • AirBus
  • Cummins
  • Intel
  • Sony